In order to examine the relationship between stage at initial diagnosis and management costs for cervical cancer, a detailed cost audit over 5 years was conducted on a sample of patients diagnosed in 1990 in one U.K. region. The mean costs of managing pre-invasive carcinoma (£386) were found to be significantly lower than those of stage 1 invasive carcinoma (£6623) and both were lower than the costs of invasive cancer at stages 2–4 (£10 910, £10 579 and £11 035, respectively). A comparison of management costs for cervical cancer with those of breast cancer by stage revealed both that the former are invariably higher and that the cost-by-stage profiles for the two diseases are dissimilar.
Mendeley saves you time finding and organizing research
Choose a citation style from the tabs below